Balke, Else M <br/><br/>
SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients.  [electronic resource] 

 -  Diabetologia  07 2018 
 - 1623-1632 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0428 
<br/><br/><label>Standard No.: </label>10.1007/s00125-018-4609-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allografts<br/>Biomarkers--blood<br/>Blood Glucose--drug effects<br/>Body Mass Index<br/>Clinical Trials as Topic<br/>Diabetes Mellitus, Type 1--blood<br/>Female<br/>HLA-A24 Antigen--genetics<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--therapeutic use<br/>Insulin-Secreting Cells--immunology<br/>Islets of Langerhans Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Polymorphism, Genetic<br/>Recovery of Function<br/>Retrospective Studies<br/>Risk Factors<br/>Treatment Outcome<br/>Zinc Transporter 8--genetics